We are live on
!
Find out more
ETC
Exchange Traded Concepts Portfolio holdings
AUM
$21.9B
1-Year Est. Return
68.6%
This Fund
S&P 500
This Quarter
Est. Return
+7.82%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
–
AUM
$478M
AUM Growth
–
Cap. Flow
+$463M
Cap. Flow
% of AUM
96.68%
Top 10 Holdings %
Top 10 Hldgs %
41.42%
Holding
487
New
487
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$25.7M |
| 2 |
Franklin Resources
BEN
|
+$22.4M |
| 3 |
DXC Technology
DXC
|
+$21.7M |
| 4 |
Nucor
NUE
|
+$21.5M |
| 5 |
Macy's
M
|
+$21.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.82% |
| 2 | Technology | 12.97% |
| 3 | Healthcare | 12.11% |
| 4 | Financials | 11.99% |
| 5 | Materials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Keysight
KEYS
$52.7B
| $52K | 0.01% |
+507
| New | +$51.9K |
|
277
Novanta
NOVT
$5.01B
| $52K | 0.01% |
+593
| New | +$51.2K |
|
278
Globus Medical
GMED
$10.7B
| $51K | 0.01% |
+873
| New | +$47.4K |
|
279
NovoCure
NVCR
$2.01B
| $48K | 0.01% |
+571
| New | +$46.1K |
|
280
Editas Medicine
EDIT
$411M
| $46K | 0.01% |
+1,540
| New | +$38.5K |
|
281
HEICO Corp Class A
HEI.A
$35.9B
| $46K | 0.01% |
+511
| New | +$48.7K |
|
|
282
HEICO Corp
HEI
$49.6B
| $45K | 0.01% |
+394
| New | +$48.5K |
|
283
Alnylam Pharmaceuticals
ALNY
$38B
| $44K | 0.01% |
+384
| New | +$38.3K |
|
284
PepsiCo
PEP
$191B
| $40K | 0.01% |
+293
| New | +$39.9K |
|
285
Johnson & Johnson
JNJ
$645B
| $31K | 0.01% |
+211
| New | +$28.6K |
|
|
URG
286
Ur-Energy
URG
$497M
| $29K | 0.01% |
+48,652
| New | +$28.7K |
|
287
Accenture
ACN
$94.6B
| $28K | 0.01% |
+133
| New | +$25.9K |
|
288
Ross Stores
ROST
$77.6B
| $24K | 0.01% |
+207
| New | +$23.3K |
|
289
Biogen
BIIB
$30B
| $23K | ﹤0.01% |
+77
| New | +$21.4K |
|
290
VF Corp
VFC
$6.78B
| $23K | ﹤0.01% |
+228
| New | +$20.4K |
|
291
Humana
HUM
$46.2B
| $21K | ﹤0.01% |
+56
| New | +$17.8K |
|
292
Merck
MRK
$327B
| $19K | ﹤0.01% |
+214
| New | +$17.6K |
|
293
UnitedHealth
UNH
$380B
| $18K | ﹤0.01% |
+62
| New | +$16.2K |
|
294
TJX Companies
TJX
$173B
| $16K | ﹤0.01% |
+254
| New | +$15K |
|
295
Cognizant
CTSH
$22.4B
| $15K | ﹤0.01% |
+242
| New | +$15K |
|
296
Motorola Solutions
MSI
$70.2B
| $15K | ﹤0.01% |
+94
| New | +$15.5K |
|
297
SiriusXM
SIRI
$10.5B
| $14K | ﹤0.01% |
+193
| New | +$13K |
|
298
Brown-Forman Class A
BF.A
$12.6B
| $13K | ﹤0.01% |
+213
| New | +$13.1K |
|
299
Target
TGT
$63.7B
| $13K | ﹤0.01% |
+99
| New | +$11.6K |
|
|
ANSS
300
DELISTED
Ansys
ANSS
| $12K | ﹤0.01% |
+48
| New | +$11.4K |
|
Similar funds
DSA
IC
AM
BA
PAG
AA
Exchange Traded Concepts's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Exchange Traded Concepts, which disclosed 487 positions worth $478M. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Cardinal Health: 496,944 shares worth $25.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, followed by Technology and Healthcare.
- Exchange Traded Concepts's largest Q4 2019 buy was Cardinal Health: 496,944 shares worth $25.1M.
- Exchange Traded Concepts's ten largest holdings make up 41% of its $478M portfolio in Q4 2019.
- Exchange Traded Concepts disclosed 487 positions in Q4 2019, its first 13F filing on record.
Based on Exchange Traded Concepts's 13F filing for Q4 2019, filed 22 Jan 2020.